dr. lin on cns activity with her2-directed tkis in her2 breast cancer
Published 4 years ago • 76 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
1:56
dr. lin on developing systemic therapies for patients with brain metastases in her2 breast cancer
-
1:19
dr. lin on the treatment landscape in her2 metastatic breast cancer
-
1:17
dr. lin on updated findings of her2climb study in her2 breast cancer brain mets
-
0:57
dr. marks on the role of tkis in her2-positive breast cancer
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
14:18
a new treatment for breast cancer patients with brain metastases: an interview with dr. nancy lin
-
3:44
her2 breast cancer: brain metastasis prevalence & later-line therapy
-
1:02
dr. freedman on neratinib plus capecitabine for cns disease from her2-positive breast cancer
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
1:11
novel her-2 targeted agents show promise in treating cns metastases
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
0:50
dr. white on cns metastases in her2 breast cancer
-
1:52
dr. murthy on de-escalation strategies in her2-positive breast cancer
-
1:52
her2climb regimen can be used earlier in her2 metastatic breast cancer
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases